CCL2 and prostate cancer: Although CCL2 in the above studies displayed an immunosuppressive function, another study in prostate cancer found that the immunosuppression was due to different additional secretions accompanied with CCL2 secreted by senescent cells and modulation of these secretions activated the anti-tumor immunity while maintaining high CCL2 levels (Toso et al., 2014).